Results 161 to 170 of about 3,000 (187)

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis

The Lancet Infectious Diseases
Individuals exposed to a person with infectious multidrug-resistant or rifampicin-resistant (MDR-RR) tuberculosis are at risk of developing tuberculosis disease. Historically, insufficient empirical evidence for preventive treatment in this group has permitted inadequate guidance for clinical decision making.
James A, Seddon, Jay, Achar, Amyn A, Malik, Jennifer, Hughes, Joseph, Burzynski, Cheng, Chen, Justin T, Denholm, Gunta, Dravniece, Greg J, Fox, Jennifer, Furin, Evgenia, Geliukh, Olga, Goncharova, Lorenzo, Guglielmetti, Anthony D, Harries, Anneke C, Hesseling, Binh Hoa, Nguyen, Fungai, Kavenga, Uzma, Khan, Yousra, Kherabi, Nana, Kiria, Yulene, Kock, Qiao, Liu, Anita, Mesic, David A J, Moore, Angel, Mubanga, Lenny, Naidoo, Diana, Nilsen, Alberto, Piubello, Anja, Reuter, Michael L, Rich, Srinath, Satyanarayana, H Simon, Schaaf, Ingrid, Schoeman, Alena, Skrahina, Zarir, Udwadia, Palwasha Y, Khan, Hanif, Esmail, Leonardo, Martinez   +37 more
openaire   +2 more sources

The pattern of resistance development to rifampicin in mycobacterium tuberculosis

Tubercle, 1972
Abstract Pattern of resistance development to rifampicin of tubercle bacilli is an obligatory ‘single-step' pattern. There is only one phenotype of resistance to rifampicin. Tubercle bacilli are either susceptible or resistant to this antibiotic, and there is no intermediate level of resistance between sensitivity and high resistance.
openaire   +2 more sources

Development of Drug Resistance to Rifampicin

Chemotherapy, 2009
A, Manten, L J, Van Wijngaarden
openaire   +2 more sources

Rifampicin-resistant tuberculosis

The Lancet, 1995
BeverleyA Wynne, Sunil Gupta
openaire   +1 more source

What the Hel: recent advances in understanding rifampicin resistance in bacteria

FEMS Microbiology Reviews, 2022
Tomáš Kouba, Jarmila Hnilicová, Libor Krasny   +2 more
exaly  

The Inappropriateness of Using Rifampicin E-Test to Predict Rifabutin Resistance in Helicobacter pylori

Journal of Infectious Diseases, 2022
Mohammed Benghezal, Hong Li, Hong Tang   +2 more
exaly  

Shorter regimens for multidrug-/rifampicin-resistant TB

The International Journal of Tuberculosis and Lung Disease, 2023
I, Felker, A, Trajman
openaire   +2 more sources

Isoniazid/rifampicin resistance

Reactions Weekly, 2017
openaire   +1 more source

Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region

Emerging Microbes and Infections, 2021
Rongchuan Zhao, Lang Bao, Tao Luo
exaly  

Rifampicin-resistant Mycobacterium tuberculosis

The Lancet, 1995
AndréC. Weltman, SusanP. Righi, GeorgeT. DiFerdinando, RobertJ. Jovell, JeffreyR. Driscoll   +4 more
openaire   +1 more source